Economic burden of tobacco related diseases in India: executive summary
The report on “Economic Burden of Tobacco Related Diseases in India”, supported by the Ministry of Health & Family Welfare, Government of India and the WHO Country Office for India, was developed by the Public Health Foundation of India (PHFI).
The report estimates direct and indirect costs from all diseases caused due to tobacco use and four specific diseases namely, respiratory diseases, tuberculosis, cardiovascular diseases and cancers. The report also highlights that tobacco use and the associated costs are creating an enormous burden for the nation.
The total economic costs attributable to tobacco use from all diseases in India in the year 2011 amounted to a staggering Rs. 1,04,500 crores. Looking through GDP lens this is 1.16 percent of GDP and 12 percent more than the combined state and central government expenditure on health care in 2011.
According to the report, massive direct medical costs of tobacco attributable diseases amount to Rs.16,800 crore and associated indirect morbidity cost of Rs. 14,700 crore. The cost from premature mortality is Rs. 73,000 crores, indicating a substantial productive loss to the nation, the report states.